Joseph K. Belanoff
2013
In 2013, Joseph K. Belanoff earned a total compensation of $2.3M as Chief Executive Officer and President at Corcept Therapeutics, a 142% increase compared to previous year.
Compensation breakdown
| Bonus | $400,000 |
|---|---|
| Option Awards | $1,398,438 |
| Salary | $525,925 |
| Total | $2,324,363 |
Belanoff received $1.4M in option awards, accounting for 60% of the total pay in 2013.
Belanoff also received $400K in bonus and $525.9K in salary.
Rankings
In 2013, Joseph K. Belanoff's compensation ranked 3,368th out of 12,286 executives tracked by ExecPay. In other words, Belanoff earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,368 out of 12,286 | 73rd |
Division Manufacturing | 1,139 out of 4,612 | 75th |
Major group Chemicals And Allied Products | 304 out of 1,466 | 79th |
Industry group Drugs | 208 out of 1,160 | 82nd |
Industry Pharmaceutical Preparations | 172 out of 890 | 81st |
Source: SEC filing on April 22, 2016.
Belanoff's colleagues
We found four more compensation records of executives who worked with Joseph K. Belanoff at Corcept Therapeutics in 2013.
News
Corcept Therapeutics CEO Joseph Belanoff's 2021 pay jumps 91% to $11M
April 25, 2022
Corcept Therapeutics CEO Joseph Belanoff's 2020 pay rises 16% to $5.8M
April 22, 2021
Corcept Therapeutics CEO Joseph Belanoff's 2019 pay falls 21% to $5M
April 27, 2020
Corcept Therapeutics CEO Joseph Belanoff's 2018 pay jumps 48% to $6.3M
April 24, 2019